# Mesoblast

**Canonical:** https://apis.io/providers/mesoblast/  
**Website:** https://mesoblast.com/  
**APIs profiled:** 0

Mesoblast Limited is an Australian regenerative medicine company headquartered in Melbourne, founded in 2004 by Silviu Itescu and listed on the ASX (MSB) and Nasdaq (MESO). It develops allogeneic cellular medicines based on mesenchymal lineage cells, including remestemcel-L for steroid-refractory acute graft versus host disease and rexlemestrocel-L for chronic heart failure and chronic low back pain. Its website answered our crawler with a bot challenge, and we found no public developer API or documentation.

## Kin Score — 4.0 / 100 (minimal)

Scored 2026-10-31 under rubric 0.25.0. Trend: flat (+0.0 from 4.0).

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 11.8 (matched via fallback).

## Agent readiness — 14.4 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | served |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | served |
| Protected Resource Metadata | verified |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Mesoblast Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Regenerative Medicine, Cell Therapy, Pharmaceuticals, Australia

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/mesoblast/). Scores are computed from the provider's own public artifacts under a published rubric.